Generics BulletinBiocon Biologics is aiming to build on its previous success in expanding access to diabetes care in Malaysia after partnering with local non-profit oncology organization the National Cancer Society of
Generics BulletinIndian giant Biocon Limited has celebrated receiving local approval for its generic liraglutide, referencing Novo Nordisk’s Victoza. India’s Central Drugs Standard Control Organisation approved the ge
Generics BulletinBiocon Limited is looking to raise INR45bn ($526.95m), largely to meet debt obligations from the investment in its subsidiary Biocon Biologics. During the earnings call for the fiscal fourth quarter a
Generics BulletinMarking its first year of being a fully integrated biosimilars company , Biocon Biologics has a packed calendar with five launches expected over the next 12 to 18 months. These products include off-p